Impairment of the intracellular insulin signaling pathway plays a critical role in the pathogenesis of Alzheimer’s disease, as insulin may indirectly enhance the cleavage of APP due to controlling the γ-secretase complex, increasing the level of Aβ [208]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.